Alpha Cognition Inc. (ACOG)
NASDAQ: ACOG · Real-Time Price · USD
5.49
-0.46 (-7.73%)
At close: May 12, 2026, 4:00 PM EDT
5.65
+0.16 (2.91%)
After-hours: May 12, 2026, 5:18 PM EDT
Alpha Cognition Revenue
In the year 2025, Alpha Cognition had annual revenue of $10.22M. Alpha Cognition had revenue of $2.79M in the quarter ending December 31, 2025.
Revenue (ttm)
$10.22M
Revenue Growth
n/a
P/S Ratio
11.70
Revenue / Employee
n/a
Employees
n/a
Market Cap
119.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.22M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Agenus | 114.20M |
| Verrica Pharmaceuticals | 35.58M |
| Innate Pharma | 10.57M |
| Equillium | 4.39M |
| Alps Group | 3.74M |
| Connect Biopharma Holdings | 64.00K |
| NeOnc Technologies Holdings | 39.99K |
| Genelux | 8.00K |
ACOG News
- 14 days ago - Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026 - Business Wire
- 15 days ago - Alpha Cognition Inc. to Participate in Three Upcoming Investor Conferences - Business Wire
- 22 days ago - Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig - Business Wire
- 25 days ago - Craig-Hallum bullish on Alpha Cognition, initiates with a Buy - TheFly
- 25 days ago - Alpha Cognition initiated with a Buy at Craig-Hallum - TheFly
- 27 days ago - Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 weeks ago - Alpha Cognition granted U.S. patent for ALPHA-1062 in brain injury - TheFly
- 5 weeks ago - Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury - Business Wire